{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T14:38:03Z","timestamp":1786718283751,"version":"build-2736575974"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Pharmacol"],"published-print":{"date-parts":[[2015]]},"DOI":"10.4103\/0253-7613.161258","type":"journal-article","created":{"date-parts":[[2015,7,21]],"date-time":"2015-07-21T05:15:05Z","timestamp":1437455705000},"page":"375","source":"Crossref","is-referenced-by-count":12,"title":["Antimicrobial drug prescribing patterns for community-acquired pneumonia in hospitalized patients: A retrospective pilot study from New Delhi, India"],"prefix":"10.4103","volume":"47","author":[{"given":"Anita","family":"Kotwani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santosh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PrafullaKumar","family":"Swain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JC","family":"Suri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SN","family":"Gaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0253-7613.161258-1","first-page":"323","volume-title":"Revised SWAB guidelines for antimicrobial therapy of community-acquired pneumonia","author":"Schouten","year":"2005","journal-title":"Neth J Med"},{"key":"key-10.4103\/0253-7613.161258-2","first-page":"170","volume-title":"New guidelines for the management of adult community-acquired pneumonia","author":"Armitage","year":"2007","journal-title":"Curr Opin Infect Dis"},{"key":"key-10.4103\/0253-7613.161258-3","unstructured":"World Health Organisation. The Evolving Threat of Antimicrobial Resistance: Options for Action. Switzerland, Geneva: World Health Organisation; 2012. Available from: http:\/\/www.whqlibdoc.who.int\/publications\/2012\/9789241503181_eng.pdf. [Last accessed on 2015 Apr 04]."},{"key":"key-10.4103\/0253-7613.161258-4","first-page":"550","volume-title":"Adult community-acquired pneumonia in central London","author":"McNabb","year":"1984","journal-title":"J R Soc Med"},{"key":"key-10.4103\/0253-7613.161258-5","first-page":"380","volume-title":"Antimicrobial drug prescribing for pneumonia in ambulatory care","author":"MacDougall","year":"2005","journal-title":"Emerg Infect Dis"},{"key":"key-10.4103\/0253-7613.161258-6","first-page":"74","volume-title":"Study of the antibiotic prescription practice for safety purposes for inpatients hospitalized due to pneumonia","author":"Natalia","year":"2010","journal-title":"Marmara Pharm J"},{"key":"key-10.4103\/0253-7613.161258-7","first-page":"99","volume-title":"Trends in antibiotic use among outpatients in New Delhi, India","author":"Kotwani","year":"2011","journal-title":"BMC Infect Dis"},{"key":"key-10.4103\/0253-7613.161258-8","doi-asserted-by":"crossref","unstructured":"Molstad S, Cars O, Struwe J. Strama - A Swedish working model for containment of antibiotic resistance. Euro Surveill 2008;13:pii=19041","DOI":"10.2807\/ese.13.46.19041-en"},{"key":"key-10.4103\/0253-7613.161258-9","first-page":"vi3","volume-title":"European Surveillance of Antimicrobial Consumption (ESAC): Outpatient antibiotic use in Europe (1997-2009)","author":"Adriaenssens","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"key-10.4103\/0253-7613.161258-10","first-page":"745","volume-title":"European Surveillance of Antimicrobial Consumption (ESAC): Value of a point-prevalence survey of antimicrobial use across Europe","author":"Zarb","year":"2011","journal-title":"Drugs"},{"key":"key-10.4103\/0253-7613.161258-11","unstructured":"World Health Organisation. How to Investigate Drug use in Health Facilities: Selected Drug Use Indicators. The Organization WHO\/DAP\/93.1. Switzerland, Geneva: World Health Organisation; 1993."},{"key":"key-10.4103\/0253-7613.161258-12","unstructured":"World Health Organization. Using Indicators to Measure Country Pharmaceutical Situations: Fact Book on WHO Level I and Level II Monitoring Indicators. Harvard Medical School and Harvard Pilgrim Health (DACP) and WHO\/TCM\/2006.2. Switzerland, Massachusetts: World Health Organization; 2006."},{"key":"key-10.4103\/0253-7613.161258-13","first-page":"335","volume-title":"Combating inappropriate use of medicines","author":"Holloway","year":"2011","journal-title":"Expert Rev Clin Pharmacol"},{"key":"key-10.4103\/0253-7613.161258-14","unstructured":"Delhi Society for Promotion of Rational Use of Drugs. Acute diarrhea. In: Sharma S, Sethi GR, Gupta U, editors. Standard Treatment Guidelines: A Manual for Medical Therapeutics. 3 rd ed. New Delhi: BI Publications; 2009. p. 119-20."},{"key":"key-10.4103\/0253-7613.161258-15","first-page":"1730","volume-title":"Guidelines for the management of adults with community-acquired pneumonia.Diagnosis, assessment of severity, antimicrobial therapy, and prevention","author":"Niederman","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"key-10.4103\/0253-7613.161258-16","first-page":"347","volume-title":"Practice guidelines for the management of community-acquired pneumonia in adults.Infectious Diseases Society of America","author":"Bartlett","year":"2000","journal-title":"Clin Infect Dis"},{"key":"key-10.4103\/0253-7613.161258-17","first-page":"S27","volume-title":"Infectious Diseases Society of America\/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults","author":"Mandell","year":"2007","journal-title":"Clin Infect Dis"},{"key":"key-10.4103\/0253-7613.161258-18","first-page":"iii1","volume-title":"BTS guidelines for the management of community acquired pneumonia in adults: Update 2009","author":"Lim","year":"2009","journal-title":"Thorax"},{"key":"key-10.4103\/0253-7613.161258-19","first-page":"794","volume-title":"Antimicrobial resistance determinants and future control","author":"Harbarth","year":"2005","journal-title":"Emerg Infect Dis"},{"key":"key-10.4103\/0253-7613.161258-20","first-page":"1446","volume-title":"Antibiotic resistance-the problem intensifies","author":"Levy","year":"2005","journal-title":"Adv Drug Deliv Rev"},{"key":"key-10.4103\/0253-7613.161258-21","first-page":"514","volume-title":"Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes","author":"Albrich","year":"2004","journal-title":"Emerg Infect Dis"},{"key":"key-10.4103\/0253-7613.161258-22","first-page":"12","volume-title":"Antibiotic consumption and link to resistance","author":"Goossens","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"key-10.4103\/0253-7613.161258-23","first-page":"S27","volume-title":"Guidelines for diagnosis and management of community- and hospital-acquired pneumonia in adults: Joint ICS\/NCCP(I) recommendations","author":"Gupta","year":"2012","journal-title":"Lung India","ISSN":"https:\/\/id.crossref.org\/issn\/0970-2113","issn-type":"print"},{"key":"key-10.4103\/0253-7613.161258-24","first-page":"281","volume-title":"Rationalizing antibiotic use to limit antibiotic resistance in India","author":"Ganguly","year":"2011","journal-title":"Indian J Med Res","ISSN":"https:\/\/id.crossref.org\/issn\/0971-5916","issn-type":"print"},{"key":"key-10.4103\/0253-7613.161258-25","unstructured":"World Health Day. Combat Drug Resistance: No Action Today Means no Cure Tomorrow. Geneva: Statement by WHO Director-General, Dr. Margaret Chan; 2011. Available from: http:\/\/www.who.int\/mediacentre\/news\/statements\/2011\/whd_20110407\/en\/. [Last accessed on 2014 Apr 09]."},{"key":"key-10.4103\/0253-7613.161258-26","first-page":"S53","volume-title":"Antimicrobial stewardship","author":"Fishman","year":"2006","journal-title":"Am J Med"},{"key":"key-10.4103\/0253-7613.161258-27","first-page":"S18","volume-title":"Antimicrobial stewardship programs: How to start and steer a successful program","author":"Drew","year":"2009","journal-title":"J Manag Care Pharm"},{"key":"key-10.4103\/0253-7613.161258-28","first-page":"775","volume-title":"Application of antimicrobial stewardship to optimise management of community acquired pneumonia","author":"Bosso","year":"2011","journal-title":"Int J Clin Pract"},{"key":"key-10.4103\/0253-7613.161258-29","first-page":"955","volume-title":"Improvement of process-of-care and outcomes after implementing a guideline for the management of community-acquired pneumonia: A controlled before-and-after design study","author":"Capelastegui","year":"2004","journal-title":"Clin Infect Dis"},{"key":"key-10.4103\/0253-7613.161258-30","first-page":"751","volume-title":"Resource use and cost of care for patients hospitalised with community acquired pneumonia: Impact of adherence to infectious diseases society of america guidelines","author":"Orrick","year":"2004","journal-title":"Pharmacoeconomics"},{"key":"key-10.4103\/0253-7613.161258-31","first-page":"1013","volume-title":"Interventions that can reduce inappropriate prescribing in the elderly: A systematic review","author":"Kaur","year":"2009","journal-title":"Drugs Aging"}],"container-title":["Indian Journal of Pharmacology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:33:18Z","timestamp":1786714398000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0253-7613.161258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015]]}},"alternative-id":["161258"],"URL":"https:\/\/doi.org\/10.4103\/0253-7613.161258","relation":{},"ISSN":["0253-7613"],"issn-type":[{"value":"0253-7613","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]}}}